The role of allergen challenge chambers in the evaluation of anti-allergic medication: an international consensus paper
- 31 January 2006
- journal article
- Published by Wiley in Clinical & Experimental Allergy Reviews
- Vol. 6 (2), 31-59
- https://doi.org/10.1111/j.1365-2222.2005.00099.x
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Economic impact and quality-of-life burden of allergic rhinitisCurrent Medical Research and Opinion, 2004
- Correlation of environmental factors with asthma and rhinitis symptoms in Tulsa, OKAnnals of Allergy, Asthma & Immunology, 2004
- Decrements in vigilance and cognitive functioning associated with ragweed-induced allergic rhinitisAnnals of Allergy, Asthma & Immunology, 2002
- Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unitAnnals of Allergy, Asthma & Immunology, 2002
- Quality of life indices may be predictive of placebo and medication response to treatment for allergic rhinitisAnnals of Allergy, Asthma & Immunology, 2001
- Quality of life in patients with allergic rhinitisAnnals of Allergy, Asthma & Immunology, 2000
- Interpreting atmospheric pollen counts for use in clinical allergy: spatial variabilityAnnals of Allergy, Asthma & Immunology, 2000
- Environmental exposure unit: a system to test anti-allergic treatmentAnnals of Allergy, Asthma & Immunology, 1999
- Allergen Immunotherapy: Therapeutic Vaccines for Allergic DiseasesAnnals of Allergy, Asthma & Immunology, 1998
- Quantitative intranasal pollen challenges: III. The priming effect in allergic rhinitisJournal of Allergy, 1969